Health and Healthcare

Eli Lilly : LLY

All Eli Lilly Articles

618 Articles

Douglas A. McIntyre | Feb 26, 2010 at 3:54 AM EST

The Drug Lords, The Men Who Run The Global Phamaceutical Industry

There are twelve major pharmaceutical firms that dominate this industry worldwide. Their combined market value is over $1 trillion with total…

Douglas A. McIntyre | Jan 26, 2010 at 9:06 AM EST

Top Day Trader Alerts (AAPL, MRNA, NVO, LLY, AMLN, VMW, CTXS)

These are the top day trader and active trader alert stocks. We have more details and analysis via a link…

Douglas A. McIntyre | Jan 5, 2010 at 3:51 AM EST

Media Digest 1/5/2010 Reuters, WSJ, NY Times, FT, Bloomberg

Reuters: Kraft (NYSE:KFT) sold it pizza business to Nestle and lifted the cash portion of its deal to buy Cadbury (NYSE:CBY).…

Douglas A. McIntyre | Sep 15, 2009 at 4:04 AM EDT

Media Digest 9/15/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Reuters: China say data show the US tire tariffs are unfair. Reuters: A Fed policy debate has begun now that…

Douglas A. McIntyre | Sep 14, 2009 at 12:18 PM EDT

Eli Lilly (LLY): America’s Most Stable Companies Keep Cutting Jobs

The rate at which unemployment is growing has slowed recently and is no longer running more than 700,000 jobs lost a…

Douglas A. McIntyre | Aug 10, 2009 at 10:56 AM EDT

The War On Diabetes Heats Up (NVO, AMLN, LLY, MNKD, PFE, VVUS, BMY, AZN, ARNA, GERN, STEM, OREX, GNBT, SPEX, ORMP, HDIX, PODD)

Diabetes is becoming an epidemic in the U.S. and the Western World. The ties to obesity are often direct, so…

Douglas A. McIntyre | Aug 10, 2009 at 9:11 AM EDT

Top Day Trader Alerts (FRE, FNM, PCLN, RIMM, LLY, MCD, TRW, YRCW)

These are this Monday’s top day trader and active trader alert stocks. More detailed price and volume data is provided…

Douglas A. McIntyre | Jul 22, 2009 at 4:01 AM EDT

The Next Blockbuster Drugs: A $170 Billion Opportunity

Safety and efficacy data are critical to drug candidates. But what really makes a potential drug attractive is strong top-line…

Douglas A. McIntyre | Jul 21, 2009 at 7:40 AM EDT

Top Day Trader Alerts (ALKS, LLY, SNY, MRK, SPPI, LXK, BSX, JDAS, IDIX, PKG, CVBF, WERN)

These are some of this morning’s top stocks to watch for active trading today based on pre-market and after-hours volume…

Douglas A. McIntyre | Jul 13, 2009 at 10:25 AM EDT

Biotech & BioHealth Business Daily (PFE, MRK, BAX, BDSI, SPPI, GNBT, AVII, CEGE, BBH, GILD, LLY, SNY, BMY, OSIP)

Here are some of today’s top stories affecting key drug and biotech stocks, accompanied with links through to more detailed…

Douglas A. McIntyre | Jul 8, 2009 at 9:47 AM EDT

BioHealth Business Daily (AMGN, NVS, AMLN, LLY, ALKS, NVO, LLY, VICL, SCLN, ARNA)

These are some of the top stories affecting key drug and biotech stocks that are covered with more in-depth details…

Douglas A. McIntyre | Jun 17, 2009 at 6:36 PM EDT

The Biotech Industry Prepares For A Wave Of Consolidation

Underscoring just how much big pharma will depend on biotech acquisitions for future revenue, an analysis published by Evaluate Pharma…

Douglas A. McIntyre | May 27, 2009 at 1:34 PM EDT

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

We have compiled an updated lengthy 2009 American Society of Clinical Oncology, or ASCO, document showing many company cancer data…

Douglas A. McIntyre | May 14, 2009 at 4:56 PM EDT

Previewing 2009 ASCO Abstracts (ABII, ALTH, ARQL, CLDX, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, OGXI, OSIP, PPHM, PFE, SNTA, ZIOP)

We are just about to get the first round of abstracts from companies presenting data at this year’s American Society…

Douglas A. McIntyre | Apr 7, 2009 at 6:59 AM EDT

Top Analyst Downgrades (ANSS, CBT, ED, CFR, DUK, LLY, EL, GGP, HW, ISRG, OMTR, RBS)

These are some of the top analyst downgrades and cautious research calls we have seen from Wall Street early this…

1 … 37 38 39 40 41 42

Eli Lilly : LLY

All Eli Lilly Articles

The Drug Lords, The Men Who Run The Global Phamaceutical Industry

Top Day Trader Alerts (AAPL, MRNA, NVO, LLY, AMLN, VMW, CTXS)

Media Digest 1/5/2010 Reuters, WSJ, NY Times, FT, Bloomberg

Media Digest 9/15/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Eli Lilly (LLY): America’s Most Stable Companies Keep Cutting Jobs

The War On Diabetes Heats Up (NVO, AMLN, LLY, MNKD, PFE, VVUS, BMY, AZN, ARNA, GERN, STEM, OREX, GNBT, SPEX, ORMP, HDIX, PODD)

Top Day Trader Alerts (FRE, FNM, PCLN, RIMM, LLY, MCD, TRW, YRCW)

The Next Blockbuster Drugs: A $170 Billion Opportunity

Top Day Trader Alerts (ALKS, LLY, SNY, MRK, SPPI, LXK, BSX, JDAS, IDIX, PKG, CVBF, WERN)

Biotech & BioHealth Business Daily (PFE, MRK, BAX, BDSI, SPPI, GNBT, AVII, CEGE, BBH, GILD, LLY, SNY, BMY, OSIP)

BioHealth Business Daily (AMGN, NVS, AMLN, LLY, ALKS, NVO, LLY, VICL, SCLN, ARNA)

The Biotech Industry Prepares For A Wave Of Consolidation

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

Previewing 2009 ASCO Abstracts (ABII, ALTH, ARQL, CLDX, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, OGXI, OSIP, PPHM, PFE, SNTA, ZIOP)

Top Analyst Downgrades (ANSS, CBT, ED, CFR, DUK, LLY, EL, GGP, HW, ISRG, OMTR, RBS)

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

Eli Lilly : LLY

All Eli Lilly Articles

The Drug Lords, The Men Who Run The Global Phamaceutical Industry

Top Day Trader Alerts (AAPL, MRNA, NVO, LLY, AMLN, VMW, CTXS)

Media Digest 1/5/2010 Reuters, WSJ, NY Times, FT, Bloomberg

Media Digest 9/15/2009 Reuters, WSJ, NYTimes, FT, Bloomberg

Eli Lilly (LLY): America’s Most Stable Companies Keep Cutting Jobs

The War On Diabetes Heats Up (NVO, AMLN, LLY, MNKD, PFE, VVUS, BMY, AZN, ARNA, GERN, STEM, OREX, GNBT, SPEX, ORMP, HDIX, PODD)

Top Day Trader Alerts (FRE, FNM, PCLN, RIMM, LLY, MCD, TRW, YRCW)

The Next Blockbuster Drugs: A $170 Billion Opportunity

Top Day Trader Alerts (ALKS, LLY, SNY, MRK, SPPI, LXK, BSX, JDAS, IDIX, PKG, CVBF, WERN)

Biotech & BioHealth Business Daily (PFE, MRK, BAX, BDSI, SPPI, GNBT, AVII, CEGE, BBH, GILD, LLY, SNY, BMY, OSIP)

BioHealth Business Daily (AMGN, NVS, AMLN, LLY, ALKS, NVO, LLY, VICL, SCLN, ARNA)

The Biotech Industry Prepares For A Wave Of Consolidation

Full 2009 ASCO Cancer & Oncology Primer (ABII, AEZS, ALTH, AMGN, APPA, ARQL, BMY, CLDX, CELG, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, MITI, OGXI, OSIP, PPHM, PFE, ROSG, SNTA, TRBN, ZIOP, ZGEN)

Previewing 2009 ASCO Abstracts (ABII, ALTH, ARQL, CLDX, CTIC, CGRB, LLY, EXEL, GHDX, GSK, IMGN, MEDX, MDVN, OGXI, OSIP, PPHM, PFE, SNTA, ZIOP)

Top Analyst Downgrades (ANSS, CBT, ED, CFR, DUK, LLY, EL, GGP, HW, ISRG, OMTR, RBS)

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple’s $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not

NVIDIA’s New Quantum‑AI Models Are Impressive — and the Market Doesn’t Seem Ready to Price the Step‑Change

Featured Reads

A 70-Year-Old With $1.4 Million Faces a $62,000 RMD That Pushes Him Into a Higher Tax Bracket

A Couple's $1.2 Million Portfolio Faces a 3.9% Withdrawal Rate That Feels Safe but Is Not